Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 23, 2025

Text Messaging for Diabetes Prevention and Care in Argentina: Implementation Challenges and Lessons Learned (Preprint)

View Full Paper
Ask AI
Bookmark
Share

Authors

ANAnalía NejamisLGLaura GutiérrezMLMaría Victoria López

Discussion

Loading...

Member takes

Overview

Implementation challenges and lessons from a WhatsApp intervention in diabetes care highlight strategies for public health engagement.

Key Points

  • The WhatsApp-based intervention engaged 11,029 participants, with 32.8% diagnosed with diabetes.
  • High engagement was observed, with 91.1% reading the initial enrollment message and an 88.7% adherence rate for educational content.
  • Challenges included technical issues with message delivery and server overload, impacting participant experience.
  • The intervention's success suggests potential for scaling WhatsApp-based diabetes care in low-resource settings.

Cite This Study

Nejamis et al. (2025) studied this question.

synapsesocial.com/papers/689a061be6551bb0af8cdb58https://doi.org/10.2196/preprints.81098
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effectiveness of a WhatsApp-based communication on improving access to antenatal care interventions in sub-Saharan Africa: A randomized control health facility trial2025
  2. 2Mobile App–Based Intervention and Cardiovascular Risk Factors in Patients With Uncontrolled Type 2 Diabetes2025 · 6 citations
  3. 3WeChat-Based Intervention for Glycemic Control in Patients with Type 2 Diabetes Mellitus: A Multicenter Randomized Controlled Trial (Preprint)2025
  4. 4Effectiveness and Feasibility of a BCW-Informed WeChat Text-Messaging Intervention to Improve Medication Adherence After PCI: A 12-Week Quasi-Experimental Study (Preprint)2025
  5. 5Teleconsultation for Managing Physiological Risk Factors of Preventable Non-Communicable Diseases in Indonesian Adults: A Protocol for a Randomized Controlled Trial (Preprint)2025